Tumor Immunology and Immunotherapy

Suzhou Dushu Lake Conference Center
October 28 - November 1, 2013

September 16, 2013

Download Flyer

Organized by:
Xuetao Cao, Chinese Academy of Medical Sciences, China
Xin-Yuan Fu, National University of Singapore, SINGAPORE
Olivera Finn, University of Pittsburgh School of Medicine, USA
Cornelis Melief, Leiden University Medical Center, The Netherlands

We are pleased to announce the Cold Spring Harbor Asia conference on Tumor Immunology and Immunotherapy, which will be held at the Suzhou Dushu Lake Conference Center in Suzhou, China, located approximately 60 miles west of Shanghai. The conference will begin at 7:00pm on the evening of Monday October 28, and will conclude after the lunch on Friday November 1, 2013.

The conference will include eight oral sessions and one poster session. Many talks will be selected from the openly submitted abstracts on the basis of scientific merit and relevance. Social events throughout the conference provide ample opportunity for informal interactions.

Major Topics:
1. Cancer vaccines
2. Antibody therapy
3. Adoptive T cell therapy
4. Combination of immunotherapy with other therapies
5. Cancer, inflammation and immunosuppression
6. Immune escape of cancer
7. Aging, immunity and cancer
8. Oncogenic viruses, immunity and immunotherapy

Keynote Speakers:
David Baltimore, California Institute of Technology , USA
Engineering Immunologic Protection and Therapy
Xiaodong Wang, National Institute of Biological Sciences, China
Abstract title: TNFalpha and TLR3/4 induced necrosis pathway

Invited Speakers:
Jean Pierre Abastado, Singapore Immunology Network, Singapore
Abstract title: Cancer cells hijack immune cells for dissemination and metastasis.
Jannie Borst, The Netherlands Cancer Institute, The Netherlands
Abstract title: Mechanistic insights in T-cell costimulation by the CD27/CD70 pathway encourage application in cancer immunotherapy
Jay Berzofsky, National Cancer Institute, USA
Abstract title: Cancer Vaccines: Basic strategies and clinical translation
Vincenzo Bronte, University of Verona, Italy
Abstract title: Molecular and metabolic control of adaptive immunity by tumor-induced myelopoiesis
Xuetao Cao, Chinese Academy of Medical Sciences, China
Abstract title: New cell subsets in tumor immune escape and metastasis
Yuan Chang, University of Pittsburgh Cancer Institute, USA
Abstract title: Merkel cell polyomavirus: a model in tumorigenesis and immunity
Lieping Chen, Yale School of Medicine, USA
Abstract title: Inhibiting co-inhibitors for immunotherapy of cancer
Olivera Finn, University of Pittsburgh School of Medicine, USA
Abstract title: Disease associated antigens as targets for cancer immunosurvellance and candidates for prophylactic cancer vaccines
Xin-Yuan Fu, National University of Singapore, Singapore
Abstract title: An Inducible Cancer Metastatic Niche Mediated by Endothelial STAT3
Yang-Xin Fu, The University of Chicago, USA
Abstract title: Changing tumor microenvironment by local ablative radiation and modified antibody for better immunotherapy
Yukai He, Georgia Regents University Cancer Center, USA
Abstract title: Engineering epitope-optimized AFP-based gene vaccines to prevent autochthonous hepatocellular carcinoma
Erica Jensen Jarolim, Medical University Vienna, Austria
Abstract title: Comparative oncology: Development of xenogenic vaccines and recombinant antibodies for dog mammary cancer patients.
Dieter Kabelitz, University of Kiel, Germany
Abstract title: Towards improving immunotherapeutic strategies with human gamma/delta T-cells
Yutaka Kawakami, Keio University School of Medicine, Japan
Abstract title: Different tumor immunoenvironments among patients and their modification by molecular targeted therapy
Binfeng Lu, University of Pittsburgh School of Medicine, USA
Abstract title: Danger signal IL-33 and antitumor Immunity
Ignacio Melero, University of Navarra, Spain
Abstract title: unfolding CD137-based cancer immunotherapy
Cornelis Melief, Leiden University Medical Center, The Netherlands
Abstract title: TLR-ligand peptide conjugates for superior therapeutic vaccination against immunogenic cancers
Ira Mellman, Genentech, USA
Abstract title: Oncology meets immunology: targeting PD-L1 in combination
Andrew Mellor, Georgia Regents University, USA
Abstract title: A Tale with a STING: Pivotal pathways that control immune responses to DNA
Graham Pawelec, University of Tuebingen Center for Medical Research, Germany
Abstract title: Immunosenescence and cancer
Zhihai Qin ,Chinese Academy of Sciences, China
Abstract title: S100A4(FSP-1)promotes liver fibrosis and hepatocellular carcinoma
Michel Sadelain, Memorial Sloan-Kettering Cancer Center, USA
Abstract title: Targeting tumors with genetically enhanced T lymphocytes
Mark Smyth, Queensland Institute of Medical Research in Brisbane, Australia
Abstract title: Receptor ligand interactions that regulate tumor growth and metastases
Cassian Yee, UT MD Anderson Cancer Center, USA
Abstract title: Adoptive T Cell Therapy of Cancer: Age of Renaissance
Hua Yu, City of Hope Duarte, USA
Abstract title: Pathways to Targeting STAT3: Transition into the Clinic
Rong-Fu Wang, The Methodist Hospital Research Institute Houston, USA
Abstract title: Innate signaling and antigen-specific cancer immunotherapy
Limin Zheng, Sun Yat-sen University, China
Abstract title: Macrophage Plasticity in Distinct Microenvironments of Human Tumors
Weiping Zou, University of Michigan Medical School, USA
Abstract title: Immune elements shape cancer stemness

We encourage abstracts to contain new and unpublished materials. The abstracts must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers. Status (fellow's talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers.

Fellowship:
We are eager to have as many young people as possible attend since they are likely to benefit most from this meeting. A certain number of presentations by graduate students and postdocs in this conference will be selected as fellowship (USD $200-$500) awards. For more details, please visit Stipends

We look forward to seeing you at Suzhou in October 2013.

Sponsored by:

Package Content:

Please kindly note:

1. The early & normal price will be available if the full payment is finished before the exact due date.
For USD participants, we will automatically change your package price to the update one if we could not successfully charge the full payment from your registered credit card before the deadline.
For CNY participants, we will automatically change your package price to the update one if our bank account could not receive your full payment by wire transfer before the deadline.

2. For Student Package registered participants, please add your roommate requirement during the online registration. Otherwise, we’ll assign you a roommate among other student participants.

3. For late registrations, your housing & registration materials may not be guaranteed since the order is usually made in advance.

4. Please inform us your request on extra day (USD 80/CNY 500 per day) and food (vegetarian, kosher…etc.) during the online registration or email us as early as possible so that we could make relevant arrangement accordingly.

5.We offer CSHA endowed student package for graduate students (student ID is required). This special offer only includes the meeting session pass. Housing, food and social activities are not included in the package.

Currency converter